Document is current
Any future updates will be listed below
-
Authors
Garcia-Salinas, Rodrigo https://orcid.org/0000-0002-5928-1092
Mejia-Maggi, Nataly https://orcid.org/0000-0002-6734-425X
Almada, Felicia https://orcid.org/0009-0007-8121-1318
Magri, Sebastian https://orcid.org/0009-0005-5433-2726
Navarro-Compán, Victoria https://orcid.org/0000-0002-4527-852X
- License Information
-
More Information
Article History
Received: 10 March 2025
Accepted: 9 April 2025
First Online: 25 April 2025
Declarations
:
: RG-S: has received research grants and/or consultancy fees from Abbvie, Eli Lilly, Janssen, Novartis, Pfizer, Sanofi, UCB, Roche, Amgen, BMS, and Sandoz. NM-M and FA: They have no conflict of interest to declare. SM: has received research grants and/or consultancy fees from: Abbvie, Novartis, Astra Zeneca, GSK and Biogen. VN-C: has received research grants/honoraria from AbbVie, Janssen, Lilly, Novartis, Pfizer and UCB.
